Holen Sie sich die Stockscreener-App
134.35
2.43%
3.19
Handel nachbörslich:
134.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$131.16
Offen:
$131.33
24-Stunden-Volumen:
1.16M
Relative Volume:
0.68
Marktkapitalisierung:
$20.53B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
17.02
EPS:
7.8957
Netto-Cashflow:
$943.00M
1W Leistung:
-0.44%
1M Leistung:
+5.33%
6M Leistung:
+33.89%
1J Leistung:
+2.61%
1-Tages-Spanne:
$130.42
$134.44
1-Wochen-Bereich:
$130.42
$135.95
52-Wochen-Spanne:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
134.35 | 20.04B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
592.51 | 217.70B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.40 | 161.70B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
669.99 | 54.02B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.95 | 38.58B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.37 | 38.39B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Biomarker Discovery Market to Reach US$ 54.19 Billion by 2033 - openPR.com
273,111 Shares in Illumina, Inc. $ILMN Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Illumina stock at a crossroads: genomics giant tests investor patience as Wall Street recalibrates e - AD HOC NEWS
Japan Nucleic Acid Isolation and Purification Market is Driven - openPR.com
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Illumina, Inc. $ILMN Shares Bought by Cwm LLC - MarketBeat
Pacer Advisors Inc. Acquires New Position in Illumina, Inc. $ILMN - MarketBeat
Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
Take Profit: Is Illumina Inc. stock undervalued vs historical averagesJuly 2025 Short Interest & AI Driven Price Predictions - moha.gov.vn
Swedbank AB Grows Position in Illumina, Inc. $ILMN - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Genomics Market Outlook: Market to Reach US$ 118.2 Billion - openPR.com
Illumina Inc ILU Stock Analysis and ForecastTechnical Breakout Signals & Fast Growing Capital Growth - earlytimes.in
Is Illumina Inc Gaining or Losing Market Support? - Sahm
Illumina, Inc. $ILMN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat
Canaccord Genuity Maintains Illumina (ILMN) Hold Recommendation - Nasdaq
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Douglas Lane & Associates LLC Acquires 18,914 Shares of Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. (ILU) stock could rally stronglySwing Trade & Stepwise Trade Signal Guides - Улправда
Illumina (ILMN): Evaluating the Stock’s Valuation After Its Strategic AI-Genomics Partnership With MyOme - Yahoo Finance
Why hedge funds are buying Illumina Inc. stockJuly 2025 Rallies & Risk Controlled Stock Alerts - Улправда
Can Illumina Inc. stock deliver consistent earnings growthJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - Улправда
Is Illumina Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Fast Gain Stock Trading Tips - DonanımHaber
Why Illumina Inc. (ILU) stock stays on buy listsStop Loss & AI Powered Buy and Sell Recommendations - DonanımHaber
Is Illumina Inc. stock undervalued vs historical averages2025 Year in Review & Smart Money Movement Alerts - ulpravda.ru
Will Illumina Inc. stock outperform international peersWeekly Investment Report & Expert Verified Movement Alerts - ulpravda.ru
Is Illumina Inc. stock supported by innovation pipelineWeekly Trading Summary & Real-Time Price Movement Reports - Улправда
“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina
DNA/Gene Microarray Market Growth Potential Examined Through - openPR.com
Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Discipline and Rules-Based Execution in ILMN Response - news.stocktradersdaily.com
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat
How AstraZeneca improved their genomics processing to be 60% faster, 70% more cost-effective - Amazon Web Services (AWS)
Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Illumina To Webcast Upcoming Investor Conference - marketscreener.com
Meet three scientists behind Illumina’s spatial assay breakthrough - Illumina
Gene Prediction Tool Industry Report 2025: Precision Genomics, - openPR.com
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
How to watch Illumina's J.P. Morgan healthcare conference webcast - Stock Titan
JP Morgan Maintains Illumina (ILMN) Neutral Recommendation - Nasdaq
Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):